The vaccine is developed by Vaccine and BiologicalProduction No. 1 (VABIOTECH). It is one of the four companies that are developingCOVID-19 vaccines in Vietnam, along with the Institute of Vaccines and MedicalBiologicals (IVAC), the Centre for Research and Production of Vaccines andBiologicals (POLYVAC), and Nanogen Pharmaceutical Biotechnology (NANOGEN).
Nanocovax by NANOGEN is Vietnam’s first candidatevaccine against the novel coronavirus SARS-CoV-2 to reach the human trialstage.
The highest dose, 75mcg, of Nanocovax was given tothree volunteers in Hanoi on January 12.
The Nha Trang-based IVAC has also been authorised tocarry out human clinical tests for its Covivac.
According to Associate Professor Dr Chu Van Men,Director of the Military Medical University’s Centre for Clinical Trials andBioequivalence, Vietnam expects to collect all necessary data on clinicaltesting by the end of 2021 before it can consider mass vaccination./.